Orbimed Advisors LLC Third Harmonic Bio, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 5,779,071 shares of THRD stock, worth $20.6 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
5,779,071
Previous 5,779,071
-0.0%
Holding current value
$20.6 Million
Previous $78.3 Million
24.06%
% of portfolio
1.61%
Previous 1.85%
Shares
1 transactions
Others Institutions Holding THRD
# of Institutions
93Shares Held
40.2MCall Options Held
100Put Options Held
0-
Atlas Venture Life Science Advisors, LLC10.4MShares$37.1 Million17.65% of portfolio
-
General Atlantic LLC New York, NY3.37MShares$12 Million1.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$11.4 Million1.53% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.93MShares$10.5 Million0.02% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.51MShares$8.94 Million4.21% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $144M